Brief: Redcare Pharmacy On Track To Meet FY Guidance For All Elements
06/05/2025 05:44
May 6 (Reuters) - Redcare Pharmacy NV RDC.DE: REDCARE PHARMACY Q1 ADJUSTED EBITDA EUR 9.1 MILLION REDCARE PHARMACY Q1 SALES EUR 717 MILLION VERSUS. IBES ESTIMATE EUR 715.7 MILLION REDCARE PHARMACY NV - Q1 TOTAL SALES INCREASED 28% TO EUR 717M REDCARE PHARMACY NV - Q1 ADJUSTED. EBITDA IMPROVED EUR 14M VERSUS. PRIOR QUARTER TO EUR +9M AND MARGIN FROM -0.7% TO 1.3%; PRIOR YEAR, ADJUSTED. EBITDA OF EUR 12M, MARGIN OF 2.1% REDCARE PHARMACY NV - Q1 ACTIVE CUSTOMER BASE REACHED 13.1M, 1.9M HIGHER THAN PRIOR YEAR AND UP 0.6M FROM END OF Q4, DRIVEN BY NEW E-RX CUSTOMERS. REDCARE PHARMACY NV - ON TRACK TO MEET FULL-YEAR GUIDANCE FOR ALL ELEMENTS REDCARE PHARMACY NV - MID- TO LONGER-TERM GUIDANCE CONTINUES TO BE AN ADJUSTED EBITDA MARGIN IN EXCESS OF 8% Further company coverage: RDC.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))